Logo image of OTC.CA

OCUMETICS TECHNOLOGY CORP (OTC.CA) Stock Price, Quote, News and Overview

TSX-V:OTC - TSX Venture Exchange - CA67577H1047 - Common Stock - Currency: CAD

0.305  -0.01 (-1.61%)

OTC.CA Quote, Performance and Key Statistics

OCUMETICS TECHNOLOGY CORP

TSX-V:OTC (2/11/2025, 7:00:00 PM)

0.305

-0.01 (-1.61%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High0.4
52 Week Low0.25
Market Cap36.53M
Shares119.77M
Float64.61M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO08-29 2018-08-29


OTC.CA short term performance overview.The bars show the price performance of OTC.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -2 -4 -6

OTC.CA long term performance overview.The bars show the price performance of OTC.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15 -20

The current stock price of OTC.CA is 0.305 CAD. In the past month the price decreased by -1.61%. In the past year, price decreased by -7.58%.

OCUMETICS TECHNOLOGY CORP / OTC Daily stock chart

OTC.CA Latest News and Analysis

OTC.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
BLCO.CA BAUSCH + LOMB CORP 26.48 8.11B
ZEN.CA ZENTEK LTD N/A 161.26M
COO.CA OSTROM CLIMATE SOLUTIONS INC N/A 3.99M

About OTC.CA

Company Profile

OTC logo image Ocumetics Technology Corp. engages in the development of bio lens to completely eliminate the need for corrective lenses, especially for people over 45 years of age. The company is headquartered in Calgary, Alberta. The company went IPO on 2018-08-29. The firm specializes in adaptive lens designs. The company is in the preclinical study stage of development of an intraocular lens. The company is focused on developing intraocular lenses for people over 45 years of age. The Ocumetics lens, which is an expandable intraocular lens that fits within the natural lens compartment of the eye to eliminate the need for corrective lenses. The company is designed to allow the eye’s natural muscle activity to shift focus from distance to nearby. The Lens consists of self-adapting suspension systems that modulate curvature change. The Lens’s suspension systems are comprised of cushions that are designed to conform to unique parameters of each recipient’s eye. When ciliary muscles relax, during sleep or when the eye focuses upon distant objects, the optical interface is compressed into its high energy state by expansion of the suspension system.

Company Info

OCUMETICS TECHNOLOGY CORP

1250, 639 - 5th Avenue S.W.

Calgary ALBERTA CA

Employees: 0

Company Website: https://ocumetics.com/

Investor Relations: http://ocumetics.com/investors/

Phone: 14036507718

OTC.CA FAQ

What is the stock price of OTC.CA?

The current stock price of OTC.CA is 0.305 CAD.


What is the symbol for OCUMETICS TECHNOLOGY CORP stock?

The exchange symbol of OCUMETICS TECHNOLOGY CORP is OTC and it is listed on the TSX Venture Exchange exchange.


On which exchange is OTC.CA stock listed?

OTC.CA stock is listed on the TSX Venture Exchange exchange.


Is OTC.CA a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for OTC.CA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of OTC.CA.


Does OTC.CA stock pay dividends?

OTC.CA does not pay a dividend.


What is the Price/Earnings (PE) ratio of OTC.CA?

OTC.CA does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).


OTC.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

OTC.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to OTC.CA. Both the profitability and financial health of OTC.CA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OTC.CA Financial Highlights

Over the last trailing twelve months OTC.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by 33.18% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -103.47%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%0.47%
Sales Q2Q%N/A
EPS 1Y (TTM)33.18%
Revenue 1Y (TTM)N/A

OTC.CA Ownership and Analysts


Ownership
Inst OwnersN/A
Ins Owners44.85%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A